A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways

• Anne-Sophie Hamy ,

  Contributed equally to this work with: Anne-Sophie Hamy, Hélène Bonsang-Kitzis

  Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

  http://orcid.org/0000-0003-4430-3022

  ⨯
• Hélène Bonsang-Kitzis ,

  Contributed equally to this work with: Anne-Sophie Hamy, Hélène Bonsang-Kitzis

  Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Department of Surgery, Institut Curie, Paris, France

  ⨯
• Marick Lae,

  Affiliation Department of Tumor Biology, Institut Curie, Paris, France

  ⨯
• Matahi Moarii,

  Affiliations Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, U900, INSERM, Institut Curie, Paris, France

  ⨯
• Benjamin Sadacca,

  Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Laboratoire de Mathématiques et Modélisation d’Evry, Université d’Évry Val d’Essonne, Evry, France

  ⨯
• Alice Pinheiro,

  Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

  ⨯
• Marion Galliot,

  Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

  ⨯
• Judith Abecassis,

  Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, U900, INSERM, Institut Curie, Paris, France

  ⨯
• Cecile Laurent,

  Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

  ⨯
• Fabien Reyal

  * E-mail: fabien.reyal@curie.fr

  Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Department of Surgery, Institut Curie, Paris, France

  ⨯